Kimberly Kraig Thompson - 26 Apr 2022 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
26 Apr 2022
Net transactions value
$0
Form type
4
Filing time
28 Apr 2022, 17:11:04 UTC
Previous filing
19 Aug 2021
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -50,044 -0.02% 203,307,567 26 Apr 2022 Direct F1, F3
transaction KBLB Common Stock Sale -50,000 -0.02% 203,257,567 27 Apr 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on April 26, 2022 at $0.072.
F2 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on April 27, 2022 at $0.071.
F3 Includes 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson, and the remainder consists of common stock Mr. Thompson owns.